Pliant Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
PLRX on Nasdaq
Location
331 Oyster Point Boulevard, South San Francisco, California

Insiders trading volume in the past year

Pliant Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $68.4M Nov 29, 2022
Bernard Coulie President and CEO, Director $10.3M -$891K -7.95% Jul 10, 2024
Keith Lamont Cummings Chief Financial Officer $3.26M -$295K -8.29% Jul 10, 2024
Hans Hull Chief Business Officer $2.86M -$283K -9.02% Jul 10, 2024
Eric Lefebvre Chief Medical Officer $2.46M -$320K -11.5% Jul 10, 2024
Mike Ouimette General Counsel & Corp. Sec'y $1.09M -$178K -14.1% Jul 10, 2024
Lily Cheung Chief Human Resource Officer $462K Jan 23, 2024
E. Krognes Director $111K Jun 13, 2024
Smital Shah Director $55.7K Jun 13, 2024
Gayle Crowell Director $55.7K Jun 13, 2024
Thomas A. MCCOURT Director $55.7K Jun 13, 2024
Darren S. Cline Director $55.7K Jun 13, 2024
Hoyoung Huh Director $55.7K Jun 13, 2024
Suzanne Louise Bruhn Director $55.7K Jun 13, 2024
John T. Curnutte Director $55.7K Jun 13, 2024
D. E. I. Pyott Director $55.7K Jun 13, 2024
Katharine Knobil Director $55.7K Jun 13, 2024
Neil Exter Director Jun 16, 2022
Charles J. Homcy Director Jun 29, 2021

Recent Insider Transactions by Companies or Individuals for Pliant Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.